IFN-Gamma Expression as a Predictor of Response to Immune Checkpoint Inhibitors in First-Line Metastatic Melanoma
Clinical trial NCT07436390 · COMPLETED
Trial details
- NCT number
- NCT07436390
- Sponsor
- Institute of Oncology Ljubljana
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-31
- Primary completion
- 2024-03-31
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.